Quest Raises Guidance for Full Year 2022

 

• Third quarter revenues of $2.49 billion, down 10.4% from 2021
• Third quarter reported diluted earnings per share ("EPS") of $2.17, down 46.0% from 2021; and adjusted diluted EPS of $2.36, down 40.4% from 2021
• Third quarter base business revenues of $2.17 billion, up 5.1% from 2021
• Full year 2022 reported diluted EPS now expected to be between $8.52 and $8.72; and adjusted diluted EPS expected to be between $9.75 and $9.95

https://www.biospace.com/article/releases/quest-diagnostics-reports-third-quarter-2022-financial-results-raises-guidance-for-full-year-2022/